NEW YORK, Feb. 21, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

http://www.reportlinker.com/p0778001/Rapid-Tests-and-Point-of-Care-Market-to-2017---Clinical-Chemistry-Tests-to-be-the-Major-Revenue-Generator.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

Summary

GBI Research's report, "Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator", provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the competitive landscape and market trend information on three rapid tests and POC market categories: clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market's dynamics. The report also provides profiles of the major companies operating in the rapid tests and POC market and a detailed analysis of the pipeline products in each category. Furthermore, the report reviews the details of important merger and acquisition deals that have taken place in the rapid tests and POC market over the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.

- The market size of three rapid tests and POC market categories - clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests.

- Annualized market revenue data from 2003 to 2010, forecast forward for 7 years to 2017.

- Qualitative analysis of key market trends, market drivers and restraints of each category within the rapid tests and POC market.

- The report also covers information on the leading players in the market and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global rapid tests and POC market.

- Design and develop your product's development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market the players with the most innovative pipeline.

- Develop market entry and market expansion strategies.

- Identify the key players best positioned to take advantage of emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.

- What's the next big thing in the rapid tests and POC market landscape? Identify, understand and capitalize.

- Make more informed business decisions with the aid of insightful and in-depth analysis of the global rapid tests and POC market and the factors shaping it.

1 Table of Contents1 Table of Contents 31.1 List of Tables 61.2 List of Figures 72 Introduction 82.1 GBI Research Guidance 93 Global Rapid Tests and Point of Care Market - Market Characterization 103.1 Global Rapid Tests and Point of Care Market, Revenue ($m), 2003 - 2010 103.2 Global Rapid Tests and Point of Care Market, Revenue ($m), 2010 - 2017 113.3 Global Rapid Tests and Point of Care Market, Key Market Trends 123.3.1 Decentralization of Laboratories is a Growing Trend Across the World 123.3.2 Integration of POC Devices with Hospital Information Systems is a Growing Trend 123.4 Significant Consolidation in Recent Years to Reshape the Competitive Landscape of the Industry 133.4.1 Increased Demand for Rapid Tests and POC Testing in Emerging Countries Will Drive the Growth of the Market in the Near Future 133.5 Global Rapid Tests and Point of Care, Market Dynamics 143.5.1 Global Rapid Tests and Point of Care, Market Drivers 143.5.2 Global Rapid Tests and Point of Care, Market Restraints 164 Global Rapid Tests and Point of Care Market - Market Category Analysis and Forecasts 184.1 Clinical Chemistry Rapid Tests and POC 184.1.1 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003 - 2010 184.1.2 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue Forecasts ($m), 2010 - 2017 204.2 Clinical Chemistry Rapid Tests and POC Market - Market Dynamics 214.2.1 Clinical Chemistry Rapid Tests and POC Market - Market Drivers 214.2.2 Clinical Chemistry Rapid Tests and POC Market - Market Restraints 224.3 Immunochemistry Rapid Tests Market 234.3.1 Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 234.3.2 Immunochemistry Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 - 2017 244.4 Immunochemistry Rapid Tests Market - Market Dynamics 254.4.1 Immunochemistry Rapid Tests Market - Market Drivers 254.4.2 Immunochemistry Rapid Tests Market - Market Restraints 264.5 Hematology Rapid Tests Market 264.5.1 Hematology Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 274.5.2 Hematology Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 - 2017 284.6 Hematology Rapid Tests Market - Market Dynamics 294.6.1 Hematology Rapid Tests Market - Market Drivers 294.6.2 Hematology Rapid Tests Market - Market Restraints 305 Global Rapid Tests and Point of Care Market - Country Analysis and Forecasts 315.1 Rapid Tests and Point of Care Market - Cross - Country Analysis 315.2 Revenue Forecasts, by Country, 2003 - 2017 335.2.1 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 - 2010 335.2.2 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 - 2017 345.2.3 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 - 2010 355.2.4 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 - 2017 365.2.5 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 - 2010 375.2.6 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 - 2017 385.2.7 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003 - 2010 395.2.8 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010 - 2017 405.2.9 Rapid Tests and Point of Care Market, France, Revenue ($m), 2003 - 2010 415.2.10 Rapid Tests and Point of Care Market, France, Revenue ($m), 2010 - 2017 425.2.11 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003 - 2010 435.2.12 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010 - 2017 445.2.13 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003 - 2010 455.2.14 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010 - 2017 465.2.15 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003 - 2010 475.2.16 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010 - 2017 485.2.17 Rapid Tests and Point of Care Market, China, Revenue ($m), 2003 - 2010 495.2.18 Rapid Tests and Point of Care Market, China, Revenue ($m), 2010 - 2017 505.2.19 Rapid Tests and Point of Care Market, India, Revenue ($m), 2003 - 2010 515.2.20 Rapid Tests and Point of Care Market, India, Revenue ($m), 2010 - 2017 525.2.21 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003 - 2010 535.2.22 Rapid Tests and Point of Care Market, Australia
, Revenue ($m), 2010 - 2017 545.2.23 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003 - 2010 555.2.24 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010 - 2017 566 Global Rapid Tests and Point of Care Market - Key Market Participants 576.1 F. Hoffmann - La Roche Ltd. 576.1.1 Business Overview 576.1.2 Marketed Products 576.2 Abbott Laboratories 576.2.1 Business Overview 576.2.2 Marketed products 586.3 Siemens Healthcare (Subsidiary of Siemens AG) 586.3.1 Business Overview 586.3.2 Marketed Products 586.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 596.4.1 Business Overview 596.4.2 Marketed Products: 596.5 bioMerieux S.A. (Subsidiary of Merieux Alliance Group) 606.5.1 Business Overview 606.5.2 Marketed products 606.6 DiaSorin S.p.A 606.6.1 Business Overview 606.6.2 Marketed Products: 617 Global Rapid Tests and Point of Care Market - Product Pipeline Analysis 627.1 Rapid Tests and Point of Care Market - Pipeline Product Summary 627.2 Rapid Tests and Point of Care Market - List of Pipeline Products 647.3 Rapid Tests and Point of Care - Profiles of Key Pipeline Products 667.3.1 ImmProCon Technology 667.3.2 RAPIDPoint 500 System - Lactate Assay 667.3.3 Sali - Chek Reader 667.3.4 Point Of Care Diagnostic Device 677.3.5 ACE Alera Clinical Chemistry System - Direct A1c Assay 677.3.6 Advia 120 Hematology System - IRF Test 677.3.7 Advia 2120 Hematology System - MPC Test 687.3.8 AIA - 600 II - D - dimer Test 688 Global Rapid Tests and Point of Care Market - Consolidation Landscape 698.1 Rapid Tests and Point of Care Market - Key Deals 2011 698.1.1 Sony Corporation of America Acquires Micronics 698.1.2 Roche Completes Acquisition of MTM Laboratories 698.1.3 Quest Diagnostics Completes Acquisition of Athena Diagnostics 698.1.4 Danaher Completes Acquisition of Beckman Coulter 708.2 Rapid Tests and Point of Care Market - Key Deals, 2007 - 2010 708.2.1 Merck Completes Acquisition of Millipore 708.2.2 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics 718.2.3 Inverness Medical Innovations Completes Acquisition of Concateno from Marwyn 718.2.4 bioMerieux Acquires AviaraDx 718.2.5 Siemens Medical Acquires Dade Behring 718.2.6 Roche Acquires Ventana Medical Systems 728.2.7 Bio - Rad Laboratories Acquires Diamed 729 Appendix 739.1 Definitions 739.1.1 Clinical Chemistry Rapid Tests & POC 739.1.2 Immunochemistry Rapid Tests Market 739.1.3 Haematology Rapid Tests Market 739.2 Acronyms 739.3 Research Methodology 749.3.1 Secondary Research 749.3.2 Primary Research 749.3.3 Models 759.3.4 Forecasts 759.3.5 Expert Panels 759.4 Contact Us 759.5 Disclaimer 769.6 Sources 76

1.1 List of Tables

Table 1: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003 - 2010 10Table 2: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010 - 2017 11Table 3: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003 - 2010 19Table 4: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010 - 2017 20Table 5: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 23Table 6: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 24Table 7: Hematology Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 27Table 8: Hematology Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 28Table 9: Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003 - 2017 31Table 10: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 - 2010 33Table 11: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 - 2017 34Table 12: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 - 2010 35Table 13: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 - 2017 36Table 14: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 - 2010 37Table 15: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 - 2017 38Table 16: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003 - 2010 39Table 17: Rapid Tests and Point of Care Market, the Germany, Revenue ($m), 2010 - 2017 40Table 18: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003 - 2010 41Table 19: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010 - 2017 42Table 20: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003 - 2010 43Table 21: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010 - 2017 44Table 22: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003 - 2010 45Table 23: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010 - 2017 46Table 24: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003 - 2010 47Table 25: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010 - 2017 48Table 26: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003 - 2010 49Table 27: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010 - 2017 50Table 28: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003 - 2010 51Table 29: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010 - 2017 52Table 30: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003 - 2010 53Table 31: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010 - 2017 54Table 32: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010 55Table 33: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010 - 2017 56Table 34: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary, 2010 62Table 35: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage 63Table 36: Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010 - 2011 64Table 37: Rapid Test and Point of Care Market, Global, List of Pipeline Products, 2010 - 2012 65Table 38: ImmProCon Technology, Product Status, 2011 66Table 39: RAPIDPoint 500 System, Product Status, 2011 66Table 40: Sali - Chek Reader, Product Status, 2011 66Table 41: Point Of Care Diagnostic Device, Product Status, 2011 67Table 42: ACE Alera Clinical Chemistry System - Direct A1c Assay, Product Status, 2011 67Table 43: Advia 120 Hematology System - IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011 67Table 44: Advia 2120 Hematology System - MPC (Mean Platelet Component) Test, Product Status, 2011 68Table 45: AIA (Automated Immunoassay Analyzer) - 600 II - D - dimer Test, Product Status, 2011 68

1.2 List of Figures

Figure 1: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003 - 2010 10Figure 2: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010 - 2017 11Figure 3: Rapid Tests and Point of Care Market, Market Categorization and Segmentation 18Figure 4: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003 - 2010 18Figure 5: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010 - 2017 20Figure 6: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 23Figure 7: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 24Figure 8: Hematology Rapid Tests Market, Global, Revenue ($m), 2003 - 2010 27Figure 9: Hematology Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 28Figure 10: Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003 - 2017 31Figure 11: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 - 2010 33Figure 12: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 - 2017 34Figure 13: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 - 2010 35Figure 14: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 - 2017 36Figure 15: Rapid Tests and Point of Care Market, the
UK, Revenue ($m), 2003 - 2010 37Figure 16: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 - 2017 38Figure 17: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003 - 2010 39Figure 18: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010 - 2017 40Figure 19: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003 - 2010 41Figure 20: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010 - 2017 42Figure 21: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003 - 2010 43Figure 22: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010 - 2017 44Figure 23: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003 - 2010 45Figure 24: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010 - 2017 46Figure 25: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003 - 2010 47Figure 26: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010 - 2017 48Figure 27: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003 - 2010 49Figure 28: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010 - 2017 50Figure 29: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003 - 2010 51Figure 30: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010 - 2017 52Figure 31: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003 - 2010 53Figure 32: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010 - 2017 54Figure 33: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010 55Figure 34: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010 - 2017 56Figure 35: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary (%), 2010 62Figure 36: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage 63

Companies mentioned

F. Hoffmann - La Roche Ltd.

Abbott Laboratories

Siemens Healthcare (Subsidiary of Siemens AG)

Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

bioMerieux S.A. (Subsidiary of Merieux Alliance Group)

DiaSorin S.p.A

To order this report:In Vitro Diagnostic Industry: Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

More here:
Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator